Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216933699> ?p ?o ?g. }
- W3216933699 endingPage "e053201" @default.
- W3216933699 startingPage "e053201" @default.
- W3216933699 abstract "We aimed to assess the level of prior SARS-CoV-2 infection in socially deprived neighbourhoods after the first wave of the pandemic, and to identify factors associated with seropositivity.A cross-sectional study.Three socially deprived neighbourhoods of the city of Perpignan, in the south of France, where large settled Roma communities live.People aged 6 years old or over, living in the study area. 700 people were included in the study using two-stage stratified sampling design.The study included a questionnaire and SARS-CoV-2 antibody testing by the Roche Elecsys immunoassay between 29 June and 17 July 2020.SARS-CoV-2 antibody seroprevalence was estimated from weighted data. Associated factors and reported symptoms were investigated using univariable and multivariable logistic regressions.The seroprevalence of anti-SARS-CoV-2 antibodies was 35.4% (95% CI 30.2% to 41.0%). People aged 15-64 years old had increased odds of being seropositive than those aged 65 years or over. Obese people had higher odds of being seropositive (adjusted OR (aOR)=2.0, 95% CI 1.1 to 3.8). The odds of being seropositive were higher in households with clinical COVID-19 cases (one case: aOR=2.5, 95% CI 1.3 to 5.0; several cases: aOR=6.9, 95% CI 3.1 to 15.2). In the neighbourhood with the highest measured seroprevalence, people living in a dwelling with one to two rooms had higher odds of being seropositive than those living in a four-room house (aOR=2.8, 95% CI 1.2 to 6.3). Working during the lockdown was associated with lower odds of being seropositive (aOR=0.2, 95% CI 0.03 to 1.0).Transmission of SARS-COV-2 in this vulnerable population was very high during the COVID-19 pandemic's first wave. Our results highlight the need to strengthen and adapt preventive measures taking into account all social determinants of health, especially housing conditions." @default.
- W3216933699 created "2021-12-06" @default.
- W3216933699 creator A5010381224 @default.
- W3216933699 creator A5015410965 @default.
- W3216933699 creator A5017502613 @default.
- W3216933699 creator A5039002333 @default.
- W3216933699 creator A5045267697 @default.
- W3216933699 creator A5053071361 @default.
- W3216933699 creator A5072520862 @default.
- W3216933699 creator A5076668411 @default.
- W3216933699 creator A5076683906 @default.
- W3216933699 creator A5077169891 @default.
- W3216933699 creator A5089148420 @default.
- W3216933699 creator A5090475176 @default.
- W3216933699 date "2021-11-01" @default.
- W3216933699 modified "2023-09-26" @default.
- W3216933699 title "Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study" @default.
- W3216933699 cites W1964486258 @default.
- W3216933699 cites W2008724195 @default.
- W3216933699 cites W2061616228 @default.
- W3216933699 cites W2079179371 @default.
- W3216933699 cites W2141624610 @default.
- W3216933699 cites W2596028093 @default.
- W3216933699 cites W2606411487 @default.
- W3216933699 cites W2783890475 @default.
- W3216933699 cites W2985094126 @default.
- W3216933699 cites W3013287931 @default.
- W3216933699 cites W3013896454 @default.
- W3216933699 cites W3015049708 @default.
- W3216933699 cites W3025571588 @default.
- W3216933699 cites W3033725206 @default.
- W3216933699 cites W3034285292 @default.
- W3216933699 cites W3034737101 @default.
- W3216933699 cites W3035189381 @default.
- W3216933699 cites W3038070845 @default.
- W3216933699 cites W3040552450 @default.
- W3216933699 cites W3040880499 @default.
- W3216933699 cites W3046492335 @default.
- W3216933699 cites W3048869410 @default.
- W3216933699 cites W3080296106 @default.
- W3216933699 cites W3081710107 @default.
- W3216933699 cites W3087248341 @default.
- W3216933699 cites W3091596635 @default.
- W3216933699 cites W3128674638 @default.
- W3216933699 cites W3153464075 @default.
- W3216933699 cites W3154866465 @default.
- W3216933699 cites W3182605449 @default.
- W3216933699 doi "https://doi.org/10.1136/bmjopen-2021-053201" @default.
- W3216933699 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8611237" @default.
- W3216933699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34815286" @default.
- W3216933699 hasPublicationYear "2021" @default.
- W3216933699 type Work @default.
- W3216933699 sameAs 3216933699 @default.
- W3216933699 citedByCount "9" @default.
- W3216933699 countsByYear W32169336992022 @default.
- W3216933699 countsByYear W32169336992023 @default.
- W3216933699 crossrefType "journal-article" @default.
- W3216933699 hasAuthorship W3216933699A5010381224 @default.
- W3216933699 hasAuthorship W3216933699A5015410965 @default.
- W3216933699 hasAuthorship W3216933699A5017502613 @default.
- W3216933699 hasAuthorship W3216933699A5039002333 @default.
- W3216933699 hasAuthorship W3216933699A5045267697 @default.
- W3216933699 hasAuthorship W3216933699A5053071361 @default.
- W3216933699 hasAuthorship W3216933699A5072520862 @default.
- W3216933699 hasAuthorship W3216933699A5076668411 @default.
- W3216933699 hasAuthorship W3216933699A5076683906 @default.
- W3216933699 hasAuthorship W3216933699A5077169891 @default.
- W3216933699 hasAuthorship W3216933699A5089148420 @default.
- W3216933699 hasAuthorship W3216933699A5090475176 @default.
- W3216933699 hasBestOaLocation W32169336991 @default.
- W3216933699 hasConcept C107130276 @default.
- W3216933699 hasConcept C126322002 @default.
- W3216933699 hasConcept C142052008 @default.
- W3216933699 hasConcept C142724271 @default.
- W3216933699 hasConcept C143095724 @default.
- W3216933699 hasConcept C144024400 @default.
- W3216933699 hasConcept C149923435 @default.
- W3216933699 hasConcept C151956035 @default.
- W3216933699 hasConcept C156957248 @default.
- W3216933699 hasConcept C159654299 @default.
- W3216933699 hasConcept C203014093 @default.
- W3216933699 hasConcept C2778494684 @default.
- W3216933699 hasConcept C2779134260 @default.
- W3216933699 hasConcept C2908647359 @default.
- W3216933699 hasConcept C3008058167 @default.
- W3216933699 hasConcept C45189115 @default.
- W3216933699 hasConcept C524204448 @default.
- W3216933699 hasConcept C71924100 @default.
- W3216933699 hasConcept C89623803 @default.
- W3216933699 hasConcept C99454951 @default.
- W3216933699 hasConceptScore W3216933699C107130276 @default.
- W3216933699 hasConceptScore W3216933699C126322002 @default.
- W3216933699 hasConceptScore W3216933699C142052008 @default.
- W3216933699 hasConceptScore W3216933699C142724271 @default.
- W3216933699 hasConceptScore W3216933699C143095724 @default.
- W3216933699 hasConceptScore W3216933699C144024400 @default.
- W3216933699 hasConceptScore W3216933699C149923435 @default.
- W3216933699 hasConceptScore W3216933699C151956035 @default.